Carregant...
Discovery of chemerin as the new chemoattractant of human mesenchymal stem cells
BACKGROUND: The homing capacity of human mesenchymal stem cells (hMSCs) to the injured sites enables systemic administration of hMSCs in clinical practice. In reality, only a small proportion of MSCs are detected in the target tissue, which is a major bottleneck for MSC-based therapies. We still don...
Guardat en:
| Publicat a: | Cell Biosci |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8252297/ https://ncbi.nlm.nih.gov/pubmed/34210352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-021-00631-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|